Open Access
CC BY 4.0 · Z Geburtshilfe Neonatol
DOI: 10.1055/a-2685-9833
Case Report

Management of Amniotic Fluid Embolism (AFE) using anticoagulation-free ECMO

Authors

  • Peijie Yan

    1   Department of Critical Care Medicine, Weifang People's Hospital, Shandong Second Medical University, Weifang, China (Ringgold ID: RIN372527)
    2   School of Clinical Medicine, Shandong Second Medical University, Weifang, China (Ringgold ID: RIN117907)
  • Chuihua Sun

    1   Department of Critical Care Medicine, Weifang People's Hospital, Shandong Second Medical University, Weifang, China (Ringgold ID: RIN372527)
  • Xiaoyan Ma

    1   Department of Critical Care Medicine, Weifang People's Hospital, Shandong Second Medical University, Weifang, China (Ringgold ID: RIN372527)
  • Xin Sun

    1   Department of Critical Care Medicine, Weifang People's Hospital, Shandong Second Medical University, Weifang, China (Ringgold ID: RIN372527)
  • Liming Wang

    1   Department of Critical Care Medicine, Weifang People's Hospital, Shandong Second Medical University, Weifang, China (Ringgold ID: RIN372527)
  • Qinghai Zhang

    1   Department of Critical Care Medicine, Weifang People's Hospital, Shandong Second Medical University, Weifang, China (Ringgold ID: RIN372527)

This work was supported by Key Specialty Funds for the Intensive Care Medicine Department at Weifang People's Hospital for article processing charge.
Preview

Abstract

Amniotic fluid embolism (AFE) is a critical obstetric complication characterized by the entry of amniotic fluid and its components into maternal circulation during parturition, leading to acute cardiopulmonary failure, disseminated intravascular coagulation (DIC), and anaphylactic shock. Affected patients typically exhibit abrupt onset, rapid progression, and exceedingly high mortality. Early recognition and prompt intervention are pivotal in AFE management. We present a case of AFE-induced cardiac arrest in a 35-year-old primigravida who developed acute cardiopulmonary collapse during vaginal delivery, followed by cardiac arrest. After cardiopulmonary resuscitation, massive transfusion, and crash emergency cesarean section, anticoagulant-free venoarterial extracorporeal membrane oxygenation (VA-ECMO) was initiated. Subsequent multimodal therapies – including aggressive transfusion support, uterine artery embolization for hemostasis, exploratory laparotomy, and targeted DIC management – ensured safe ECMO maintenance without device-related complications. By hospital day 3, hemodynamic and respiratory stability were achieved, enabling successful ECMO weaning. This case highlights that ECMO remains a viable therapeutic option for salvaging critically ill AFE patients with refractory hemorrhagic shock, DIC, and cardiopulmonary failure.



Publikationsverlauf

Eingereicht: 05. Mai 2025

Angenommen nach Revision: 05. August 2025

Artikel online veröffentlicht:
05. September 2025

© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/).

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany